Company / PP&E per Share
Pacira BioSciences, Inc. PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$3.04
FY2025
5-year range
$3.04 / $4.32
FY2021-FY2025
Trend
-15.8%
vs FY2024
Sector context
#28 of 191
Health Care
What the data says
Pacira BioSciences, Inc.'s pp&e per share of $3.04 is higher than 85% of companies in the Health Care sector (FY2025). PP&E per Share has declined for 4 consecutive years, from $4.32 in FY2021 to $3.04 in FY2025.
Based on SEC 10-K filings.
3.04 in FY2025 with a 5-year CAGR of -1.4%. Top quartile in the Health Care sector.
Declined from $3.79 to $3.04 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -9.5%
- 5-Year CAGR
- -1.4%
- 10-Year CAGR
- -
Sector benchmark
Top 15% in Health CareTop 15% of 191This company $3.04 Sector average $18.90
▼
-83.9% below sector average
Key checks
Key Insights
- Pacira BioSciences, Inc.'s pp&e per share has declined for 4 consecutive years.
- In FY2025, pp&e per share decreased 15.8% year-over-year.
- Ranks #28 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2021.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Negative profit margin: -14.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.04 | -15.8% |
| FY2024 | $3.61 | -4.5% |
| FY2023 | $3.79 | -7.7% |
| FY2022 | $4.10 | -5.0% |
| FY2021 | $4.32 | +32.4% |
| FY2020 | $3.26 | +28.4% |
| FY2019 | $2.54 | -5.0% |
| FY2018 | $2.67 | -6.4% |
| FY2017 | $2.86 | +4.2% |
| FY2016 | $2.74 | +9.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026